Friday, November 15, 1996 FULL SHOW | HEADLINES | NEXT: Experimental Treatment Without Consent, part 2
1996-11-15

Experimental Treatment Without Consent

download:   Audio Get CD/DVD More Formats
DONATE →
This is viewer supported news

Last month the FDA quietly abandoned a 50 year old regulation, requiring doctors to get a person’s informed consent before conducting experiments. The FDA claims the new rules benefit those needing emergency treatment. Opponents raise the specter of Nazi doctors and US radiation experiments.

Goodman plays a pre-taped interview with FDA Deputy Commissioner Mary Pendergast via phone. Pendergast explains that emergency experimental treatment must meet strict guidelines and where informed consent is not conceivable. Goodman contends that these guidelines would target homeless or others without families for experimentation, and pharmaceutical companies have something to gain by expanding their research field. Pendergast says safeguards are in place to prevent unwarranted interference by drug companies on experimental treatment.

Guests:
- Mary Pendergast, deputy commission of the FDA

Recent Shows More

Full News Hour

Stories

    2014-0730_siegman1
    "A Slaughter of Innocents": Henry Siegman, a Venerable Jewish Voice for Peace, on Gaza
    Today, a special with Henry Siegman, the former executive director of the American Jewish Congress, long described as one of the nation’s "big three" Jewish organizations along with the American Jewish Committee and the Anti-Defamation League. Henry Siegman was born in 1930 in Frankfurt, Germany. Three years later, the Nazis came to power. After fleeing Nazi troops in Belgium, his family eventually moved to the United States. His father was a leader of the European Zionist movement, pushing for the creation of a Jewish state. In...

Headlines

    There are no headlines for this date.


Creative Commons License The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.